Search Results

There are 6635 results for: content related to: Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses

  1. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  2. You have free access to this content
    Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

    American Journal of Hematology

    Volume 91, Issue 2, February 2016, Pages: 252–265, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 22 JAN 2016, DOI: 10.1002/ajh.24275

  3. You have full text access to this OnlineOpen article
    Metabolism-related pharmacokinetic drug−drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 241–253, Yi Ling Teo, Han Kiat Ho and Alexandre Chan

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12496

  4. You have free access to this content
    Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis

    International Journal of Cancer

    Volume 132, Issue 12, 15 June 2013, Pages: 2967–2974, Wei-Xiang Qi, Da-Liu Min, Zan Shen, Yuan-Jue Sun, Feng Lin, Li-Na Tang, Ai-Na He and Yang Yao

    Version of Record online : 27 DEC 2012, DOI: 10.1002/ijc.27979

  5. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma

    The Journal of Pathology

    Volume 234, Issue 2, October 2014, Pages: 277–288, Kaito Nihira, Yasuhiro Miki, Shinya Iida, Sodai Narumi, Katsuhiko Ono, Erina Iwabuchi, Kazue Ise, Kazushige Mori, Mikiyoshi Saito, Masahito Ebina, Ikuro Sato, Makoto Maemondo, Hisafumi Yamada-Okabe, Takashi Kondo and Hironobu Sasano

    Version of Record online : 18 AUG 2014, DOI: 10.1002/path.4354

  6. Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway

    ChemMedChem

    Volume 7, Issue 4, April 2012, Pages: 650–662, Dr. Anne Pick and Prof. Dr. Michael Wiese

    Version of Record online : 22 FEB 2012, DOI: 10.1002/cmdc.201100543

  7. You have free access to this content
    Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

    Cancer

    Volume 115, Issue 10, 15 May 2009, Pages: 2165–2176, Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Antoinette Wozniak and Fazlul H. Sarkar

    Version of Record online : 13 MAR 2009, DOI: 10.1002/cncr.24250

    Corrected by:

    Retraction: Retraction

    Version of Record online: 29 JUL 2016

  8. TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux

    Biopharmaceutics & Drug Disposition

    Ronilda D'Cunha, SoHyun Bae, Daryl J. Murry and Guohua An

    Version of Record online : 13 SEP 2016, DOI: 10.1002/bdd.2022

  9. You have free access to this content
    Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 748–762, Wei-Xiang Qi, Zan Shen, Li-Na Tang and Yang Yao

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12387

  10. You have free access to this content
    Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 547–556, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 12 APR 2014, DOI: 10.1002/ajh.23691

  11. Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors

    Journal of Clinical Ultrasound

    Volume 44, Issue 4, May 2016, Pages: 221–230, Sherif Moustafa, Thai H. Ho, Parth Shah, Katie Murphy, Bhargava K. Nelluri, Howard Lee, Susan Wilansky and Farouk Mookadam

    Version of Record online : 15 FEB 2016, DOI: 10.1002/jcu.22333

  12. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    Cancer

    Volume 122, Issue 19, October 1, 2016, Pages: 2941–2951, Sebastian Giebel, Anna Czyz, Oliver Ottmann, Frederic Baron, Eolia Brissot, Fabio Ciceri, Jan J. Cornelissen, Jordi Esteve, Norbert-Claude Gorin, Bipin Savani, Christoph Schmid, Mohamad Mohty and Arnon Nagler

    Version of Record online : 16 JUN 2016, DOI: 10.1002/cncr.30130

  13. You have free access to this content
    Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

    Cancer

    Volume 120, Issue 10, 15 May 2014, Pages: 1514–1519, Sima Jeha, Elaine Coustan-Smith, Deqing Pei, John T. Sandlund, Jeffrey E. Rubnitz, Scott C. Howard, Hiroto Inaba, Deepa Bhojwani, Monika L. Metzger, Cheng Cheng, John K. Choi, Jeffrey Jacobsen, Sheila A. Shurtleff, Susana Raimondi, Raul C. Ribeiro, Ching-Hon Pui and Dario Campana

    Version of Record online : 5 FEB 2014, DOI: 10.1002/cncr.28598

  14. You have free access to this content
    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

    British Journal of Clinical Pharmacology

    Volume 77, Issue 6, June 2014, Pages: 929–938, Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi and Enrico Cortesi

    Version of Record online : 22 MAY 2014, DOI: 10.1111/bcp.12231

  15. Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia

    Pediatric Blood & Cancer

    Volume 63, Issue 8, August 2016, Pages: 1332–1338, Jill Samis, Paul Lee, Donald Zimmerman, Robert J. Arceci, Meinolf Suttorp and Nobuko Hijiya

    Version of Record online : 21 APR 2016, DOI: 10.1002/pbc.26028

  16. You have full text access to this OnlineOpen article
    The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors

    STEM CELLS

    Volume 32, Issue 9, September 2014, Pages: 2324–2337, Francesca Pellicano, Mary T. Scott, G. Vignir Helgason, Lisa E. M. Hopcroft, Elaine K. Allan, Mark Aspinall-O'Dea, Mhairi Copland, Andrew Pierce, Brian J. P. Huntly, Anthony D. Whetton and Tessa L. Holyoake

    Version of Record online : 18 AUG 2014, DOI: 10.1002/stem.1748

  17. Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism

    Histopathology

    Volume 64, Issue 4, March 2014, Pages: 484–493, Toyonori Tsuzuki, Naoto Sassa, Yoshie Shimoyama, Takamitsu Morikawa, Ryoichi Shiroki, Makoto Kuroda, Akitoshi Fukatsu, Kyoko Kuwahara, Yasushi Yoshino, Ryohei Hattori and Momokazu Gotoh

    Version of Record online : 26 NOV 2013, DOI: 10.1111/his.12277

  18. You have full text access to this OnlineOpen article
    Clinical outcome of epidermal growth factor receptor-tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations

    Thoracic Cancer

    Volume 7, Issue 1, January 2016, Pages: 24–31, Hong Zhang, Hua Bai, Xiaodan Yang, Jia Zhong, Tongtong An, Jun Zhao and Jie Wang

    Version of Record online : 11 JUN 2015, DOI: 10.1111/1759-7714.12266

  19. You have free access to this content
    Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1037–1045, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 23 OCT 2012, DOI: 10.1002/ajh.23282

  20. Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors

    Clinical Pharmacology & Therapeutics

    Volume 93, Issue 3, March 2013, Pages: 215–219, C D Drenberg, S D Baker and A Sparreboom

    Version of Record online : 18 DEC 2012, DOI: 10.1038/clpt.2012.247